THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly for
in vitro testing and laboratory experimentation only.
All product information available on this website is for educational
purposes only. Bodily introduction of any kind into humans or animals
is strictly forbidden by law. This product should only be handled by
licensed, qualified professionals. This product is not a drug, food,
or cosmetic and may not be misbranded, misused or mislabeled as a drug,
food or cosmetic.
GLP2-T
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied as a tool compound in incretin-receptor signaling research. Experimental systems examine receptor co-activation, downstream GPCR-mediated signaling cascades, and pathway-level biomarker responses. All references are confined to non-clinical laboratory investigation.
Products will arrive in a lyophilized (powder) form to maximize stability and shelf life.
$79–$179Price range: $79 through $179
Select Dosage :
FREE BAC Water for Peptide Orders over $250
Buy any peptide, get a vial of the same peptide FREE. Limited time only.
What It Is
Tirzepatide is a synthetic peptide studied as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor in experimental systems.
What It’s Derived From
Tirzepatide is engineered from a modified incretin-mimetic peptide sequence incorporating structural elements that enable receptor engagement at both GIPR and GLP-1R. A fatty-acid side-chain modification enhances molecular stability and prolongs activity in controlled laboratory models.
What Research Focuses On
Research evaluates tirzepatide in in vitro and in vivo experimental models investigating incretin receptor pharmacology, G-protein–coupled receptor (GPCR) signaling dynamics, receptor co-activation mechanisms, intracellular cAMP-mediated pathways, and downstream metabolic signaling biomarkers under defined preclinical conditions.